Prognostic significance of preoperative plasma fibrinogen in endometrial cancer
- 1 November 2010
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 119 (2), 309-313
- https://doi.org/10.1016/j.ygyno.2010.07.014
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trialBritish Journal of Cancer, 2010
- Role of Systemic Inflammatory Response in Predicting Survival in Patients with Primary Operable CancerFuture Oncology, 2009
- Laparoscopic Versus Open Surgery for Endometrial Cancer: a Minimum 3-Year Follow-Up StudyAnnals of Surgical Oncology, 2009
- Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised studyThe Lancet, 2008
- Association of Elevated C-reactive Protein Levels With an Impaired Prognosis in Patients With Surgically Treated Endometrial CancerObstetrics & Gynecology, 2007
- Pretreatment plasma fibrinogen level correlates with tumor progression and metastasis in patients with squamous cell carcinoma of the esophagusJournal of Gastroenterology and Hepatology, 2007
- A Prospective Blinded Evaluation of the Accuracy of Frozen Section for the Surgical Management of Endometrial CancerObstetrics & Gynecology, 2006
- Plasma fibrinogen and serum C-reactive protein are associated with non-small cell lung cancerLung Cancer, 2006
- Tumors and FibrinogenAnnals of the New York Academy of Sciences, 2001
- Tumors: Wounds That Do Not HealNew England Journal of Medicine, 1986